Skip to main content

Cybin Inc(CYBN-NE)
Cboe CA

Today's Change
Real-Time Last Update

Cybin Inc

100 King Street West
Suite 5600
Toronto ON M5X 1C9 CAN
P: 908-764-8385

Sectors & Indices

Sector
Industry
Employees

    Profile

    Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

    Key Executives

    NameTitle
    Information not available.

    More from The Globe

    Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
    The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
    Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
    Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
    Thursday’s analyst upgrades and downgrades
    A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.
    Wednesday’s analyst upgrades and downgrades
    A Pet Valu store is pictured in Ottawa, Tuesday, Sept. 13, 2022.
    number cruncher
    Seven Canadian oil producers set to benefit from rising prices
    For Number Cruncher column in Globe Investor/ROB only.
    Bullish on Mullen Group Ltd.
    Monica Rizk
    Top non-resource stocks on the TSX with strong insider signals
    Ted Dixon
    Berkshire Hathaway shares have largest slide since Buffett’s resignation
    FILE PHOTO: A screen displays the trading information for Berkshire Hathaway inc. as traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 22, 2025. REUTERS/Brendan McDermid/File Photo

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.